Roles of voltage-dependent sodium channels in neuronal development, pain, and neurodegeneration

Journal of Pharmacological Sciences

Volumn 102, Issue 3, 2006, Pages 253-268

  Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Demyelination; Neuronal circuit development; Pain; Remyelination; Voltage dependent sodium channel

Indexed keywords

ANTIBODY; BUPIVACAINE; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; CYTOKINE; GROWTH FACTOR; INSULIN; LIDOCAINE; MEXILETINE; MUTANT PROTEIN; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; ROPIVACAINE; SCORPION VENOM; SOMATOMEDIN C; TOXIN; TSUKUBAENOLIDE; VALPROIC ACID; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ADULTHOOD; ALLODYNIA; COGNITION; DRUG MECHANISM; EMBRYO DEVELOPMENT; EPIGENETICS; ERYTHROMELALGIA; HUMAN; HYPOXIA; ISCHEMIA; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NERVE FIBER; NEUROPATHIC PAIN; NONHUMAN; OLIGODENDROGLIA; PAIN; PROTEIN EXPRESSION; REMYELINIZATION; REVIEW; SYMPATHECTOMY; SYMPATHETIC BLOCKING; SYNAPSE;

EID: 33751229668     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.CRJ06012X     Document Type: Review

References (103)

1. Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond). 1952;117:500-544.
2. Hartshorne RP, Catterall WA. Purification of the saxitoxin receptor of the sodium channel from rat brain. Proc Natl Acad Sci U S A. 1981;78:4620-4624.
3. Noda M, Shimizu S, Tanabe T, Takai T, Kayano T, Ikeda T, et al. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature. 1984;312:121-127.
4. Wiesel TN. Early explorations of the development and plasticity of the visual cortex: a personal view. J Neurobiol. 1999;41:7-9.
5. Zhang LI, Poo M-M. Electrical activity and development of neural circuits. Nat Neurosci. 2001;4 Suppl:1207-1214.
6. Fields PD. Myelination: an overlooked mechanism of synaptic plasticity? Neuroscientist. 2005;11:528-531.
7. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci. 2006;7:423-436.
8. Barres BA, Raff MC. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature. 1993;361:258-260.
9. Barres BA, Raff MC. Axonal control of oligodendrocyte development. J Cell Biol. 1999;147:1123-1128.
10. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, et al. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci U S A. 1996;93:9887-9892.
11. Stevens B, Tanner S, Fields RD. Control of myelination by specific patterns of neural impulses. J Neurosci. 1998;18:9303-9311.
12. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in responses to action potentials. Neuron. 2002;36:855-868.
13. Coman I, Barbin G, Charles P, Zalc B, Lubetzki C. Axonal signals in central nervous system myelination, demyelination and remyelination. J Neurol Sci. 2005;233:67-71.
14. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, et al. Astrocytes promote myelination in response to electrical impulses. Neuron. 2006;49:823-832.
15. Xu X, Shrager P. Dependence of axon initial segment formation of Na+ channel expression. J Neurosci Res. 2005;79:428-441.
16. Uesaka N, Hirai S, Maruyama T, Ruthazer ES, Yamamoto N. Activity dependence of cortical axon branch formation: a morphological and electrophysiological study using organotypic slice cultures. J Neurosci. 2005;25:1-9.
17. Uesaka N, Ruthazer ES, Yamamoto N. The role of neural activity in cortical axon branching. Neuroscientist. 2006;12:102-106.
18. Callaway EM, Katz LC. Effects of binocular deprivation on the development of clustered horizontal connections in cat striate cortex. Proc Natl Acad Sci U S A. 1991;88:745-749.
19. Herrmann K, Shatz CJ. Blockade of action potential activity alters initial arborization of thalamic axons within cortical layer 4. Proc Natl Acad Sci U S A. 1995;92:11244-11248.
20. Ruthazer ES, Stryker MP. The role of activity in the development of long-range horizontal connections in area 17 of the ferret. J Neurosci. 1996;16:7253-7269.
21. Catalano SM, Shatz CJ. Activity-dependent cortical target selection by thalamic axons. Science. 1998;281:559-562.
22. Dantzker JL, Callaway EM. The development of local, layer-specific visual cortical axons in the absence of extrinsic influences and intrinsic activity. J Neurosci. 1998;18:4145-4154.
23. Goldberg JL, Espinosa JS, Xu Y, Davidson N, Kovacs GTA, Barres BA. Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity. Neuron. 2002;33:689-702.
24. Singh KK, Miller FD. Activity regulates positive and negative neurotrophin-derived signals to determine axon competition. Neuron. 2005;45:837-845.
25. Hua JY, Smear MC, Baier H, Smith SJ. Regulation of axon growth in vivo by activity-based competition. Nature. 2005;434:1022-1026.
26. Ming G-I, Henley J, Tessier-Lavigne M, Song H-J, Poo M-M. Electrical activity modulates growth cone guidance by diffusible factors. Neuron. 2001;29:441-452.
27. Hanson MG, Landmesser LT. Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules. Neuron. 2004;43:687-701.
28. Pierre K, Dupouy B, Allard M, Poulain DA, Theodosis DT. Mobilization of the cell adhesion glycoprotein F3/contactin to axonal surface is activity dependent. Eur J Neurosci. 2001;14:645-656.
29. Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, Michel PP. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci. 2004;24:5922-5930.
30. Coman I, Aigrot MS, Seilhean D, Reynolds R, Girault JA, Zalc B, et al. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain. In press 2006.
31. Franklin RJM. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705-714.
32. Zhao C, Fancy SPJ, Kotter MR, Li W-W, Franklin RJM. Mechanisms of CNS remyelination-the key to therapeutic advances. J Neurol Sci. 2005;233:87-91.
33. v1.2 at nodes of Ranvier. Brain. 2006;129:1319-1329.
34. Sasaki M, Black JA, Lankford KL, Tokuno HA, Waxman SG, Kocsis JD. Molecular reconstitution of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J Neurosci. 2006;26:1803-1812.
35. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol. 2000;157:267-276.
36. Borodinsky LN, Root CM, Cronin JA, Sann SB, Gu X, Spitzer NC. Activity-dependent homeostatic specification of transmitter expression in embryonic neurons. Nature. 2004;429:523-530.
37. Waxman SG. Transcriptional channelopathies: an emerging class of disorders. Nat Rev Neurosci. 2001;2:652-659.
38. Catterall WA, Goldin A, Waxman SG. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev. 2005;57:397-409.
39. Isom LL. The role of sodium channels in cell adhesion. Front Biosci. 2002;7:12-23.
40. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, et al. Sodium channel β4, a new disulfide-linked auxiliary subunit with similarity to β2. J Neurosci. 2003;23:7577-7585.
41. Cestèle S, Catterall WA. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie. 2000;82:883-892.
42. v1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells. Front Biosci. 2004;9:1954-1966.
43. Pertin M, Ji R-R, Berta T, Powell AJ, Karchewski L, Tate SN, et al. Upregulation of the voltage-gated sodium channel β2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. J Neurosci. 2005;25:10970-10980.
44. + channel expression along axons in multiple sclerosis and its models. Trends Pharmacol Sci. 2004;25:584-591.
45. Rodriguez M. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain. 2003;126:751-752.
46. Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci. 2005;233:3-13.
47. Bechtold DA, Smith KJ. Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J Neurol Sci. 2005;233:27-35.
48. Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci U S A. 2000;97:11598-11602.
49. Craner MJ, Lo AC, Black JA, Waxman SG. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain. 2003;126:1552-1561.
50. v1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain. 2004;127:294-303.
51. 2+ exchanger. Proc Natl Acad Sci U S A. 2004;101:8168-8173.
52. Waxman SG, Dib-Hajj S. Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med. 2005;11:555-562.
53. Davis MD, O'Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136:330-336.
54. Drenth JPH, Finley WH, Breedveld GJ, Testers L, Michiels JJ, Guillet G, et al. The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am J Hum Genet. 2001;68:1277-1282.
55. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004;41:171-174.
56. v1.7 sodium channels in a painful inherited neuropathy. J Neurosci. 2004;24:8232-8236.
57. v1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005;128:1847-1854.
58. Burns TM, Te Morsche RHM, Jansen JBMJ, Drenth JPH. Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia. Br J Dermatol. 2005;153:174-177.
59. Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005;115:2010-2017.
60. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc Natl Acad Sci U S A. 1999;96:7635-7639.
61. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and their genes: dynamic expression in the normal nervous system, dysregulation in disease states. Brain Res. 2000;886:5-14.
62. v1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A. 2004;101:12706-12711.
63. v1.7 sodium channels in primary afferents. Hum Gene Ther. 2005;16:271-277.
64. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem. 2004;279:29341-29350.
65. Craner MJ, Klein JP, Renganathan M, Black JA, Waxman SG. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann Neurol. 2002;52:786-792.
66. Yamamoto R, Yanagita T, Kobayashi H, Yuhi T, Yokoo H, Wada A. Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells. J Neurochem. 1996;67:1401-1408.
67. Wada A, Yokoo H, Yanagita T, Kobayashi H. New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J Pharmacol Sci. 2005;99:128-143.
68. Yamamoto R, Yanagita T, Kobayashi H, Yokoo H, Wada A. Upregulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion. J Neurochem. 1997;68:1655-1662.
69. Shiraishi S, Yanagita T, Kobayashi H, Uezono Y, Yokoo H, Minami S, et al. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. J Pharmacol Exp Ther. 2001;297:657-665.
70. + channels in cultured bovine adrenal medullary cells. J Pharmacol Exp Ther. 2002;302:212-218.
71. Yokoo H, Shiraishi S, Kobayashi H, Yanagita T, Minami S, Yamamoto R, et al. Short- and long-term differential effects of neuroprotective drug NS-7 on voltage-dependent sodium channels in adrenal chromafin cells. Br J Pharmacol. 2000;131:779-787.
72. Shiraishi S, Yokoo H, Yanagita T, Kobayashi H, Minami S, Saitoh T, et al. Differential effects of bupivacaine enantiomers, ropivacaine and lidocaine on up-regulation of cell surface voltage-dependent sodium channels in adrenal chromaffin cells. Brain Res. 2003;966:175-184.
73. 1-subunit mRNA levels in adrenal chromaffin cells. J Neurochem. 1999;73:1749-1757.
74. Yanagita T, Kobayashi H, Yamamoto R, Kataoka H, Yokoo H, Shiraishi S, et al. Protein kinae C-α and -ε down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells. J Neurochem. 2000;74:1674-1684.
75. Shiraishi S, Shibuya I, Uezono Y, Yokoo H, Toyohira Y, Yamamoto R, et al. Heterogeneous increases of cytoplasmic calcium: distinct effects on down-regulation of cell surface sodium channels and sodium channel subunit mRNA levels. Br J Pharmacol. 2001;132:1455-1466.
76. v1.7 sodium channel α-subunit mRNA by constitutive phosphorylation of extracellular signal-regulated kinase: negative regulation of steady-state level of cell surface functional sodium channels in adrenal chromaffin cells. Mol Pharmacol. 2003;63:1125-1136.
77. Palmer LM, Stuart GJ. Site of action potential initiation in layer 5 pyramidal neurons. J Neurosci. 2006;26:1854-1863.
78. Wada A, Yokoo H, Yanagita T, Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci. 2005;99:307-321.
79. Buffelli M, Busetto G, Bidoia C, Favero M, Cangiano A. Activity-dependent synaptic competition at mammalian neuromuscular junctions. News Physiol Sci. 2004;19:85-91.
80. McCaig CD, Rajnicek AM, Song B, Zhao M. Has electrical growth cone guidance found its potential? Trends Neurosci. 2002;25:354-359.
81. Tang J, Rutishauser U, Landmesser L. Polysialic acid regulates growth cone behavior during sorting of motor axons in the plexus region. Neuron. 1994;13:405-414.
82. Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, et al. Spinal sensory neurons express multiple sodium channel α-subunit mRNAs. Brain Res Mol Brain Res. 1996;43:117-131.
83. Kim CH, Oh Y, Chung JM, Chung K. Changes in three subtypes of tetrodotoxin sensitive sodium channel expression in the axotomized dorsal root ganglion in the rat. Neurosci Lett. 2002;323:125-128.
84. Coward K, Plumpton C, Facer P, Birch R, Carlstedt T, Tate S, et al. Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states. Pain. 2000;85:41-50.
85. Coward K, Aitken A, Powell A, Plumpton C, Birch R, Tate S, et al. Plasticity of TTX-sensitive sodium channels PN1 and brain III in injured human nerves. Neuroreport. 2001;12:495-500.
86. Braz JM, Nassar MA, Wood JN, Basbaum AI. Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron. 2005;47:787-793.
87. Zylka MJ. Nonpeptidergic circuits feel your pain. Neuron. 2005;47:771-772.
88. 2-subunit regulates cell adhesion and migration. J Biol Chem. 2005;280:23251-23261.
89. Wong H-K, Sakurai T, Oyama F, Kaneko K, Wada K, Miyazaki H, et al. β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase. J Biol Chem. 2005;280:23009-23017.
90. Seishima M, Kanoh H, Izumi T, Niwa M, Matsuzaki Y, Takasu A, et al. A refractory case of secondary erythermalgia successfully treated with lumbar symphatetic ganglion block. Br J Dermatol. 2000;143:868-872.
91. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 1995;14:1084-1090.
92. Toledo-Aral JJ, Moss BL, He Z-J, Koszowski AG, Whisenand T, Levinson SR, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A. 1997;94:1527-1532.
93. Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, Waxman SG. A single sodium mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A. 2006;103:8245-8250.
94. Mørk C, Kalgaard OM, Kvernebo K. Impaired neurogenic control of skin perfusion in erythromelalgia. J Invest Dermatol. 2002;118:699-703.
95. Davis MD, Sandroni P, Rooke TW, Low PA. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol. 2003;139:1337-1343.
96. Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal rot ganglia neurons in inflammatory pain. Pain. 2004;108:237-247.
97. Boiko T, Rasband MN, Levinson SR, Caldwell JH, Mandel G, Trimmer JS, et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron. 2001;30:91-104.
98. Mews I, Bergmann M, Bunkowski S, Gullota F, Bruck W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler. 1998;4:55-62.
99. Rivera-Quiñones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med. 1998;4:187-193.
100. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury. Neurosci Lett. 1993;160:139-144.
101. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain. 1997;120:393-399.
102. Iwata A, Stys PK, Wolf JA, Chen X-H, Taylor AG, Meaney DF, et al. Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors. J Neurosci. 2004;24:4605-4613.
103. Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med. 2006;354:942-955.